Central administration of oxytocin reduces body weight in animal models that are otherwise resistant to leptin (either because of their diet‐induced obesity or as a result of defective leptin signalling), with a concomitant improvement in glucose tolerance and insulin sensitivity.7, 8, 9, 10, 11, 12. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.